Comparing the effectiveness of capecitabine versus 5-fluorouracil/leucovorin therapy for elderly Taiwanese stage III colorectal cancer patients based on quality-of-life measures (QLQ-C30 and QLQ-CR38) and a new cost assessment tool

BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer-related deaths in developed countries and its incidence increases with age. Intravenous administration of bolus 5-fluorouracil (5-FU) and leucovorin (LV) has been a standard treatment regime for stage III CRC. However, patients general...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Jen-Kou, Tan, Elise Chia-Hui, Yang, Ming-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448214/
https://www.ncbi.nlm.nih.gov/pubmed/25986478
http://dx.doi.org/10.1186/s12955-015-0261-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448214/
https://www.ncbi.nlm.nih.gov/pubmed/25986478
http://dx.doi.org/10.1186/s12955-015-0261-1

Ejemplares similares